XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 8,761,095 $ 4,910,409 $ 28,551,246 $ 12,908,679
General and administrative 3,473,210 2,307,946 10,036,564 4,655,861
Total operating expenses 12,234,305 7,218,355 38,587,810 17,564,540
Other income (expense):        
Interest (expense) income (9,212) (6,098) 217,908 (13,537)
Foreign currency (loss) gain (74,565) 975,034 283,636 2,591,008
Total other (expense) income (83,777) 968,936 501,544 2,577,471
Net loss (12,318,082) (6,249,419) (38,086,266) (14,987,069)
Other comprehensive loss:        
Foreign currency translation (168,982) (2,940,174) (836,852) (4,926,841)
Total comprehensive loss $ (12,487,064) $ (9,189,593) $ (38,923,118) $ (19,913,910)
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) $ (0.58) $ (5.29) $ (1.80) $ (12.72)
Weighted-average common shares outstanding, basic and diluted (in shares) 21,186,827 1,181,726 21,115,797 1,178,206